BioSpace News Archive

Deals

Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board

PSGL-1 identified as lead macrophage checkpoint modulator (MCM) program for development in cancer

October 21, 2019
·
4 min read
Business

Nine-Month Figures for 2019: Sartorius Continues on Its Dynamic Growth Track

Sartorius, a leading international partner of biopharmaceutical research and the industry, performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months.

October 21, 2019
·
10 min read
Business

Moberg Pharma and DongKoo Sign Agreement for MOB-015 in the Republic of Korea

Moberg Pharma AB has signed a distribution agreement with DongKoo Bio & Pharma Co., Ltd for MOB-015 in the Republic of Korea. Under the agreement DongKoo is granted exclusive rights to market and sell MOB-015 in the Republic of Korea. Moberg Pharma assumes production and supply responsibility.

October 21, 2019
·
3 min read
Policy

Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile

Promising clinical data for Cascade Net published in the Journal of NeuroInterventional Surgery

October 21, 2019
·
3 min read
Policy

Shape Memory Medical Receives CE Mark for the TrelliX® Embolic Coil System

Shape Memory Medical Inc. announced it has received CE mark for its TrelliX® Embolic Coil System.

October 21, 2019
·
3 min read
EOS imaging Announces First Cases Utilizing hipEOS 3.0 and Intellijoint HIP® Smart Navigation System via EOSlink™ at Hospital for Special Surgery (HSS)

Utilization of both technologies provides unique advantages in the optimization of Total Hip Arthroplasty (THA)

October 21, 2019
·
4 min read
FDA

United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study

United Therapeutics Corporation announced that the U.S. Food and Drug Administration has approved a supplement to the New Drug Application for Orenitram® Extended-Release Tablets reflecting data from the FREEDOM-EV study in patients with pulmonary arterial hypertension.

October 21, 2019
·
8 min read
Deals

i2020 Accelerator Invests in Developing Novel Highly-Specific Approaches to Treatment of Neurodegenerative Diseases Based on Previously Unrecognized Protein-Protein Interactions

i2020 Accelerator announced its plans to invest in a cutting-edge research program based out of the University of Turku, Finland.

October 21, 2019
·
3 min read
Deals

Emergent BioSolutions to Host 2019 Analyst & Investor Day

Emergent BioSolutions Inc. announced that the company will host an analyst and investor day on November 21, 2019 in New York City.

October 21, 2019
·
1 min read
Policy

Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037

Idera Pharmaceuticals, Inc., or the Company, announced that the U.S. Patent and Trademark Office will issue on November 5, 2019 U.S. Patent No. 10,10,463,686 entitled “Immune Modulation With TLR9 Agonists For Cancer Treatment,” which includes the Company’s investigational therapy tilsotolimod.

October 21, 2019
·
4 min read